Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis

16 Aug 2022

Abstract excerpt

Background: Ovarian-tumor (OTU) domain-containing protein 6B (OTUD6B), one of newly identified OTU deubiquitylating enzyme families, is proved to be associated with tumor progression. However, whether it plays a key role in pan-cancer still remains unknown. Methods: The profiles of OTUD6B expression in multiple cancers were analyzed using The Cancer Genome Atlas (TCGA) database. Information of protein expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to interferon and immune responses
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36052059
DOI: 10.3389/fimmu.2022.955091

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysisPMID 36052059Read ↗

Deubiquitinase OTUD3: a double-edged sword in immunity and diseaseSemantic proximity Read ↗

OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and ARSemantic proximity Read ↗

Distinct expression and prognostic value of OTU domain‑containing proteins in non‑small‑cell lung cancerSemantic proximity Read ↗

Human OTUD6B positively regulates type I IFN antiviral innate immune responses by deubiquitinating and stabilizing IRF3Semantic proximity Read ↗

Otubain 1: a non-canonical deubiquitinase with an emerging role in cancerSemantic proximity Read ↗

Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistanceSemantic proximity Read ↗

Comprehensive Pancancer Analysis of TUBB6 as a Marker for Prognosis and Immunotherapy ResponseSemantic proximity Read ↗

VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinomaSemantic proximity Read ↗

Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarkerSemantic proximity Read ↗

Comprehensive Analysis of DMRT3 as a Potential Biomarker Associated with the Immune Infiltration in a Pan-Cancer Analysis and Validation in Lung AdenocarcinomaSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy responseSemantic proximity Read ↗

VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.